Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
311. |
ECCT/13/02/01 | AMC 068 A Randomized Phase II Trial Of Chop Vs Oral Chemotherapy with Concomitant Antiretroviral Therapy in Patients with HIV-Associated Lymphoma in Sub-Saharan Africa |
Principal Investigator(s) 1. NAFTALI WISINDI BUSAKHALA Site(s) in Kenya MOI UNIVERSITY CLINICAL RESEARCH CENTER |
View |
312. |
ECCT/19/01/02 | Opt4Kids Optimizing viral load suppression in Kenyan children on antiretroviral therapy (Opt4Kids) |
Principal Investigator(s) 1. Lisa Dillabaugh Abuogi 2. Patrick Oyaro Owiti Site(s) in Kenya 1. Kisumu County Hospital (Kisumu county) 2. Ahero County Hospital (Kisumu county) 3. Nyakach County Hospital (Kisumu county) 4. Lumumba sub-County Hospital (Kisumu county) 5. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) |
View |
313. |
ECCT/15/10/04 | AZM Azithromycin (AZM) to prevent post-discharge morbidity and mortality in Kenyan children |
Principal Investigator(s) 1. Judd Walson Walson Site(s) in Kenya 1. Homa Bay County referral Hospital (Homa Bay county) 2. Kisii Teaching and referral Hospital (Kisii county) |
View |
314. |
ECCT/21/05/06 | VAC52150EBL2010 ;Phase 2 An open label, Phase 2 study to evaluate the safety and immunogenicity of an Ad26.ZEBOV booster dose in Human Immunodeficiency Virus Positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen |
Principal Investigator(s) 1. Prof. Omu Anzala Omu Anzala Site(s) in Kenya KAVI-institute of Clinical Research |
View |
315. |
ECCT/17/10/01 | Neo-Fosfo Intravenous and Oral Fosfomycin in Hospitalised Neonates with Clinical Sepsis: an open-label safety and pharmacokinetics study |
Principal Investigator(s) 1. James A Berkley Site(s) in Kenya KEMRI-WTRP |
View |